{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T09:00:53Z","timestamp":1765357253996,"version":"build-2065373602"},"reference-count":25,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"INDIVIOR"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>Analgesic opioid (AO) misuse by patients ranges from 0% to 50%. General practitioners are the first prescribers of AO. Our objective was to validate the Prescription Opioid Misuse Index (POMI) in primary care. We conducted a psychometric study in patients with chronic pain who had been taking AOs for at least 3 months and were followed in general practice. Patients responded to the POMI at inclusion and after 2 weeks. The reference used was the DSM-V. Sixty-nine GPs included 160 patients (87 women, 54.4%), mean age 56.4 \u00b1 15.2 years. The total POMI score was 1.50 \u00b1 1.27, and 73\/160 (45.6.0%) had a score \u2265 2 (misuse threshold). Internal validity was measured with the Kuder\u2013Richardson coefficient, which was 0.44. Correlations between each item and the total score ranged from 0.06 to 0.35. Test\u2013retest reliability was determined from 145 patients: Lin\u2019s concordance coefficient was 0.57 [0.46, 0.68]. Correlation with the DSM-V (Spearman\u2019s coefficient) was 0.52. The POMI does not have sufficient psychometric properties to be recommended as a tool to identify the misuse of AOs in primary care. This study clearly showed that there is a need to create a monitoring tool specific to primary care.<\/jats:p>","DOI":"10.3390\/ijerph192214845","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T02:29:32Z","timestamp":1668392972000},"page":"14845","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Real-Life Testing of the Prescription Opioid Misuse Index in French Primary Care"],"prefix":"10.3390","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9890-489X","authenticated-orcid":false,"given":"Catherine","family":"Laporte","sequence":"first","affiliation":[{"name":"Clermont Auvergne Institut Pascal (INP), CNRS, Centre Hospitalo-Universitaire (CHU) Clermont-Ferrand, Universit\u00e9 Clermont Auvergne, F-63000 Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4078-9523","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Fortin","sequence":"additional","affiliation":[{"name":"Clermont Auvergne Institut Pascal (INP), CNRS, Centre Hospitalo-Universitaire (CHU) Clermont-Ferrand, Universit\u00e9 Clermont Auvergne, F-63000 Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7801-286X","authenticated-orcid":false,"given":"Julie","family":"Dupouy","sequence":"additional","affiliation":[{"name":"Unite Mixte de Recherche (UMR) 1295 Inserm, Universit\u00e9 Toulouse III, F-31000 Toulouse, France"},{"name":"Maison de Sant\u00e9 Pluriprofessionelle Universitaire de Pins Justaret, F-31860 Pins Justaret, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Quirin","sequence":"additional","affiliation":[{"name":"Clermont Auvergne Institut Pascal (INP), CNRS, Centre Hospitalo-Universitaire (CHU) Clermont-Ferrand, Universit\u00e9 Clermont Auvergne, F-63000 Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3778-7161","authenticated-orcid":false,"given":"Bruno","family":"Pereira","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Biostatistiques, Direction de la Recherche Clinique et de l\u2019Innovation, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chouki","family":"Chenaf","sequence":"additional","affiliation":[{"name":"CHU Clermont-Ferrand, Service de Pharmacologie M\u00e9dicale, Centre d\u2019Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Universit\u00e9 Clermont Auvergne, F-63000 Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Delorme","sequence":"additional","affiliation":[{"name":"CHU Clermont-Ferrand, Service de Pharmacologie M\u00e9dicale, Centre d\u2019Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Universit\u00e9 Clermont Auvergne, F-63000 Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Mayni\u00e9-Fran\u00e7ois","sequence":"additional","affiliation":[{"name":"UMR CNRS 5558, Laboratoire de Biom\u00e9trie et Biologie \u00c9volutive (LBBE), \u00c9quipe Evaluation et Mod\u00e9lisation des Effets Th\u00e9rapeutiques (EMET), Universit\u00e9 Claude Bernard Lyon 1, F-69100 Lyon, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9dric","family":"Rat","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine G\u00e9n\u00e9rale, Universit\u00e9 de Nantes-INSERM U1302\/CNRS EMR6001-\u00c9quipe 2, F-44035 Nantes, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"Birebent","sequence":"additional","affiliation":[{"name":"Unite Mixte de Recherche (UMR) 1295 Inserm, Universit\u00e9 Toulouse III, F-31000 Toulouse, France"},{"name":"Maison de Sant\u00e9 Pluriprofessionelle Universitaire de Pins Justaret, F-31860 Pins Justaret, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Rambaud","sequence":"additional","affiliation":[{"name":"D\u00e9partement de M\u00e9decine G\u00e9n\u00e9rale, Universit\u00e9 Montpellier, F-34090 Montpellier, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2333-7357","authenticated-orcid":false,"given":"Christian","family":"Duale","sequence":"additional","affiliation":[{"name":"Unit\u00e9 de Biostatistiques, Direction de la Recherche Clinique et de l\u2019Innovation, CHU Clermont-Ferrand, F-63000 Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Kerckhove","sequence":"additional","affiliation":[{"name":"CHU Clermont-Ferrand, Service de Pharmacologie M\u00e9dicale, Centre d\u2019Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Universit\u00e9 Clermont Auvergne, F-63000 Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"No\u00e9mie","family":"Delage","sequence":"additional","affiliation":[{"name":"CHU Clermont-Ferrand, Service de Pharmacologie M\u00e9dicale, Centre d\u2019Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Universit\u00e9 Clermont Auvergne, F-63000 Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Authier","sequence":"additional","affiliation":[{"name":"CHU Clermont-Ferrand, Service de Pharmacologie M\u00e9dicale, Centre d\u2019Addictovigilance et Pharmacovigilance, Centre Evaluation et Traitement de la Douleur, Inserm, Neuro-Dol, Universit\u00e9 Clermont Auvergne, F-63000 Clermont-Ferrand, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,11,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2147\/JPR.S105892","article-title":"A review of chronic pain impact on patients, their social environment and the health care system","volume":"9","author":"Duenas","year":"2016","journal-title":"J. Pain Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ejpain.2005.06.009","article-title":"Survey of chronic pain in Europe: Prevalence, impact on daily life, and treatment","volume":"10","author":"Breivik","year":"2006","journal-title":"Eur. J. Pain"},{"key":"ref_3","first-page":"1","article-title":"How prevalent is chronic pain?","volume":"11","author":"Harstall","year":"2003","journal-title":"Pain Clin. Updates"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/BF03008120","article-title":"La douleur en m\u00e9decine g\u00e9n\u00e9rale","volume":"15","author":"Tajfel","year":"2002","journal-title":"Doul. Analg."},{"key":"ref_5","first-page":"21","article-title":"Prise en charge ambulatoire de la douleur chronique","volume":"38","author":"Blanc","year":"2007","journal-title":"Prat. Organ. Soins"},{"key":"ref_6","unstructured":"HAS (2022, September 15). Etat Des Lieux. Douleur Chronique: Les Aspects Organisationnels. Le Point de Vue des Structures Sp\u00e9cialis\u00e9es. Available online: https:\/\/www.has-sante.fr\/jcms\/c_813396\/fr\/douleur-chronique-les-aspects-organisationnels."},{"key":"ref_7","unstructured":"ANSM: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des Produits de Sant\u00e9 (2022, January 26). \u00c9tat des Lieux de la Consommation des Antalgiques Opio\u00efdes et Leurs Usages Probl\u00e9matiques. Available online: https:\/\/ansm.sante.fr\/actualites\/antalgiques-opioides-lansm-publie-un-etat-des-lieux-de-la-consommation-en-france."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.ejpain.2010.04.006","article-title":"Classification and identification of opioid addiction in chronic pain patients","volume":"14","author":"Nielsen","year":"2010","journal-title":"Eur. J. Pain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jpain.2008.10.008","article-title":"Clinical Guidelines for the Use of Chronic Opioid Therapy in Chronic Noncancer Pain","volume":"10","author":"Chou","year":"2009","journal-title":"J. Pain"},{"key":"ref_10","first-page":"259","article-title":"Les opio\u00efdes forts dans les douleurs ost\u00e9o-articulaires non canc\u00e9reuses: Revue de la litt\u00e9rature et recommandations pour la pratique clinique: Les recommandations de Limoges 2010","volume":"13","author":"Laroche","year":"2012","journal-title":"Doul. Eval. Diagn. Trait."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ejpain.2006.08.004","article-title":"Addiction to opioids in chronic pain patients: A literature review","volume":"11","year":"2007","journal-title":"Eur. J. Pain"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders, Psychiatric Association. [5th ed.].","DOI":"10.1176\/appi.books.9780890425596"},{"key":"ref_13","unstructured":"World Health Organization (2022, September 15). The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Available online: https:\/\/apps.who.int\/iris\/handle\/10665\/37958."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s12630-022-02210-7","article-title":"Transcultural validation of a French\u2013European version of the Prescription Opioid Misuse Index Scale (POMI-5F)","volume":"69","author":"Delage","year":"2022","journal-title":"Can. J. Anesth."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jsat.2008.02.001","article-title":"Prescription Opioid Misuse Index: A brief questionnaire to assess misuse","volume":"35","author":"Knisely","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/0895-4356(93)90142-N","article-title":"Cross-cultural adaptation of health-related quality of life measures: Literature review and proposed guidelines","volume":"46","author":"Guillemin","year":"1993","journal-title":"J. Clin. Epidemiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jclinepi.2010.02.006","article-title":"The COSMIN study reached international consensus on taxonomy, terminology, and definitions of measurement properties for health-related patient-reported outcomes","volume":"63","author":"Mokkink","year":"2010","journal-title":"J. Clin. Epidemiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jclinepi.2006.03.012","article-title":"Quality criteria were proposed for measurement properties of health status questionnaires","volume":"60","author":"Terwee","year":"2007","journal-title":"J. Clin. Epidemiol."},{"key":"ref_19","unstructured":"DeVellis, R.F. (2003). Scale Development: Theory and Applications, Sage."},{"key":"ref_20","first-page":"1917","article-title":"L\u2019extraordinaire d\u00e9veloppement des bo\u00eetes \u00e0 outils en m\u00e9decine g\u00e9n\u00e9rale Outils techniques, cliniques et de communication","volume":"9","author":"Aubert","year":"2013","journal-title":"Rev. Med. Suisse"},{"key":"ref_21","unstructured":"(2022, September 15). Experts in Global Domain Management and Online Brand Protection. Available online: http:\/\/www.medal.org\/org."},{"key":"ref_22","first-page":"24","article-title":"Tests et \u00e9chelles: Freins des g\u00e9n\u00e9ralistes \u00e0 leur utilisation. \u00c9tude transversale descriptive men\u00e9e dans une population de m\u00e9decins g\u00e9n\u00e9ralistes","volume":"60","author":"Cario","year":"2010","journal-title":"Supp. Rev. Prat."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1001\/jama.1995.03530080061042","article-title":"Use of methodological standards in diagnostic test research. Getting better but still not good","volume":"274","author":"Reid","year":"1995","journal-title":"JAMA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.282.11.1061","article-title":"Empirical evidence of design-related bias in studies of diagnostic tests","volume":"282","author":"Lijmer","year":"1999","journal-title":"JAMA"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addbeh.2017.05.005","article-title":"The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland","volume":"73","author":"Latkin","year":"2017","journal-title":"Addict. Behav."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/22\/14845\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:14:33Z","timestamp":1760145273000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/19\/22\/14845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,11]]},"references-count":25,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2022,11]]}},"alternative-id":["ijerph192214845"],"URL":"https:\/\/doi.org\/10.3390\/ijerph192214845","relation":{},"ISSN":["1660-4601"],"issn-type":[{"type":"electronic","value":"1660-4601"}],"subject":[],"published":{"date-parts":[[2022,11,11]]}}}